Le Qu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Renal cell carcinoma treatment 33
- Ferroptosis and cancer prognosis 8
-
- Cancer-related molecular mechanisms research 8
- Cancer Genomics and Diagnostics 2
- Co-authors
- Linhui Wang (22 shared papers)Zhenjie Wu (13 shared papers)Yi Bao (8 shared papers)Linhui Wang (13 shared papers)Bing Liu (8 shared papers)Anbang Wang (10 shared papers)Deng-Shuang Wu (5 shared papers)Cheng Yeh Chen (3 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Frontiers in Immunology (3 papers)Journal of the National Cancer Center (2 papers)PLoS ONE (2 papers)European Urology (2 papers)
- Partner nations
- ChinaPolandUnited States
In The Last Decade
Le Qu
51 papers receiving 2.3k citations
Le Qu's Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 927
- Pulmonary and Respiratory Medicine 536
- Molecular Biology 698
- Oncology 231
- Hepatology 53
Countries citing papers authored by Le Qu
This map shows the geographic impact of Le Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Qu more than expected).
Fields of papers citing papers by Le Qu
This network shows the impact of papers produced by Le Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Qu. The network helps show where Le Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Le Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA Hit paper breakdown → | 2016 | 938 |
| 2 | 2017 | 175 | |
| 3 | 2014 | 111 | |
| 4 | 2016 | 107 | |
| 5 | 2017 | 107 | |
| 6 | 2018 | 104 | |
| 7 | 2016 | 103 | |
| 8 | 2019 | 103 | |
| 9 | 2022 | 69 | |
| 10 | 2022 | 49 | |
| 11 | 2022 | 41 | |
| 12 | 2022 | 39 | |
| 13 | 2016 | 37 | |
| 14 | 2021 | 32 | |
| 15 | 2016 | 30 | |
| 16 | 2025 | 28 | |
| 17 | 2016 | 27 | |
| 18 | 2023 | 27 | |
| 19 | 2018 | 22 | |
| 20 | 2014 | 21 |
About Le Qu
Le Qu is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Endocrine and Autonomic Systems, having authored 56 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (33 papers), Cancer-related molecular mechanisms research (8 papers), Ferroptosis and cancer prognosis (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (3 papers), Extracellular vesicles in disease (2 papers), Cancer Genomics and Diagnostics (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (927 citations), Pulmonary and Respiratory Medicine (536 citations), Molecular Biology (698 citations), Oncology (231 citations) and Hepatology (53 citations). Le Qu has collaborated with scholars based in China, Poland and United States. Frequent co-authors include Linhui Wang, Zhenjie Wu, Yi Bao, Linhui Wang, Bing Liu, Anbang Wang, Deng-Shuang Wu, Cheng Yeh Chen, Jiazi Shi and Aimin Jiang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Journal of the National Cancer Center, PLoS ONE and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.